Pharmacogenetics of Response to GLP1R Agonists | MicrobiomeTrials← Back to trialsNCT05071898
Pharmacogenetics of Response to GLP1R Agonists
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2022-04-11Est. Completion: 2027-04-30
Enrollment target: 600 participants Locations- Amish Research Clinic, Lancaster, Pennsylvania, United States
Other microbiome trials you might be interested in
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disease, often compounded by obesity, that leads to serious l…
Multiple LocationsEst. completion Jan 12, 2027
Obesity
A 12-month randomized, controlled, parallel-arm trial, divided into 2 consecutive periods: (1) 6-month weight loss perio…
Chicago, United StatesCompleted Feb 1, 2025
Type 2 Diabetes Mellitus (T2DM)
Obesity (Disorder)
Overweight
Metabolic Syndrome
The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…
Almaty, KazakhstanEst. completion Nov 2026